Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Eniola Odetunde/Axios

The CEOs of 179 health care companies took home almost $2.5 billion in 2019, a majority of which came from cashing out stock, according to an Axios analysis of financial filings.

The big picture: That amount is four times what the Centers for Disease Control and Prevention had to study and prepare for all "emerging and zoonotic infectious diseases" last year, right before the novel coronavirus outbreak turned into a global pandemic.

By the numbers: The median pay of a health care CEO in 2019 was roughly $8 million, similar to 2018. Seventeen CEOs made more than $30 million each.

  • The figures were calculated by using actual realized gains of stock options and awards, which are in the annual proxy disclosures companies file with the Securities and Exchange Commission.

The highest-paid health care CEO in 2019 was Abiomed's Michael Minogue, who made $123 million — equal to roughly 16% of the medical device firm's revenue and half of its profit.

  • A spokesperson said in a statement that a vast majority of Minogue's 2019 compensation "originates from stock options and performance shares awarded over the previous 10 years." He "still owns the exercised and vested shares, is one of the larger shareholders in the company, and is currently not taking a salary during the coronavirus pandemic."
  • In 2019, Abiomed and physicians who accept money from the company lobbied the federal government to squash a proposal that would've cut Medicare payments for surgeries involving Abiomed's heart pumps. They won.

Between the lines: Support for Medicare for All dangled over the industry throughout 2019 and damaged companies' stock prices. But stocks eventually rebounded in the last two months of the year, as Wall Street forecasted a very profitable election year.

  • And higher stock prices led to more big payouts for executives at the top.

Worth noting: This year's analysis removed several CEOs whose companies were acquired, and it does not include their "golden parachute" payouts.

  • For example, the analysis excludes The Medicines Co.'s Mark Timney, who got $66.3 million after Novartis acquired his company; Ken Burdick of WellCare Health Plans, who cashed out $46.8 million after Centene's deal; and Allergan's Brent Saunders, who pocketed $38.7 million from AbbVie's buyout.
  • The analysis also does not include 2019 compensation for top executives at not-for-profit hospital systems and most Blue Cross Blue Shield insurers because it was not available.

Go deeper: Health care CEOs took home $2.6 billion in 2018

Go deeper

Dion Rabouin, author of Markets
Sep 1, 2020 - Economy & Business

Apple, Tesla and Zoom power Nasdaq to new record high

Expand chart
Data: FactSet; Chart: Axios Visuals

Tech stocks had a big day on Monday led by gains in three companies, even as U.S. equities broadly ended the day lower.

What happened: Tesla rose 12.5% during the session as traders were again inexplicably lured by its lower share price due to a five-to-one stock split. Apple added 3.5% and Zoom gained 8.6% during the day with its stock jumping by nearly 10% in after-hours trading after posting better-than-expected Q2 earnings.

Biden gets mixed grades on revolving door

Illustration: Sarah Grillo/Axios

President Biden is getting mixed marks for his reliance on industry insiders to staff his administration during its first 100 days.

Why it matters: Progressives have leaned on the new president to limit the revolving door between industry and government. A new report from the Revolving Door Project praises him on that front but highlights key hires it deems ethically questionable.

Exclusive: Sen. Coons sees new era of bipartisanship on China

Sen. Chris Coons. Photo: Kent Nishimura / Los Angeles Times via Getty Images

The Jan. 6 insurrection was a "shock to the system," propelling members of Congress toward the goal of shoring up America's ability to compete with China, Sen. Chris Coons (D-Del.) told Axios during an interview Thursday.

Why it matters: Competition between China's authoritarian model and the West's liberal democratic one is likely to define the 21st century. A bipartisan response would help the U.S. present a united front.